SCHEMBL30948622

SCHEMBL30948622

CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4P(C)C)n3)cc2N)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.59
CCNK O75909 2/20 0.58
CCNA2 P20248 2/20 0.58
CDK2 P24941 2/20 0.58
CCND3 P30281 2/20 0.58
CDK9 P50750 2/20 0.58
CDK6 Q00534 2/20 0.58
ALK Q9UM73 3/20 0.55
MAP3K7 O43318 4/20 0.53
MAPK1 P28482 2/20 0.53
MAP2K1 Q02750 2/20 0.53
FGFR1 P11362 1/20 0.53
SRC P12931 1/20 0.53
SLC2A1 P11166 2/20 0.53
AXL P30530 1/20 0.51
NEK2 P51955 1/20 0.51
BRD4 O60885 3/20 0.51
FLT3 P36888 1/20 0.51
BTK Q06187 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30948600 0.90 EGFR (0.49) EGFRCCNKCCNA2CDK2CCND3
SCHEMBL29253729 0.84 EGFR (0.81) EGFRALK
SCHEMBL30948623 0.84 EGFR (0.50) EGFRCCNKCCNA2CDK2CCND3
SCHEMBL30948584 0.83 EGFR (0.53) EGFRALKAXL
SCHEMBL30948583 0.83 EGFR (0.53) EGFRALKAXL
SCHEMBL22520206 0.83 EGFR (0.57) EGFRALKBRD4
SCHEMBL30833650 0.81 LRRK2 (0.48) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL29190653 0.81 LRRK2 (0.48) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL30948582 0.81 EGFR (0.50) EGFRCCNA2CDK2ALKMAPK1
SCHEMBL22246172 0.81 MAPK9 (0.54) EGFRCCNKCCNA2CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113677680-B EGFR inhibitor, composition and application thereof 贝达药业股份有限公司 2024-05-10 CN disclosed